Ascendis Pharma A/S (ASND) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -7.85M | 70.67M | 2.15M | -7.34M | -14.31M | -87.18M | -56.13M | -61.31M | -101.58M | -42.47M | -124.72M | -153.13M |
| Operating CF Margin % | -3.13% | 28.82% | 1.01% | -4.64% | -14.18% | -50.13% | -97.06% | -170.31% | -105.93% | -30.84% | -259.65% | -323.1% |
| Operating CF Growth % | 45.17% | 181.06% | 103.84% | 88.03% | 85.91% | -105.26% | 54.99% | 59.96% | 30.92% | 70.03% | -26.19% | -23.1% |
| Net Income | 639.69M | -33.25M | -60.99M | -38.86M | -94.63M | -38.47M | -99.2M | -109.38M | -131.03M | -86.88M | -162.22M | -121.43M |
| Depreciation & Amortization | 4.29M | 4.78M | 4.02M | 4.31M | 4.54M | 4.47M | 4.37M | 4.39M | 4.48M | 4.98M | 4.74M | 4.64M |
| Stock-Based Compensation | 0 | 0 | 30.64M | 30.02M | 25.56M | 26.22M | 26M | 26.05M | 17.28M | 15.91M | 17.18M | 19.88M |
| Deferred Taxes | 0 | 3.22M | 3.62M | 3.85M | 1.06M | 1.08M | 0 | 229K | 2.51M | 5.79M | 645K | -429K |
| Other Non-Cash Items | -583.9M | 57.33M | 229K | 37.36M | -1.34M | -36.09M | -76.22M | 40.13M | 57.03M | 32.94M | 38.97M | -19.25M |
| Working Capital Changes | -67.92M | 38.59M | 24.64M | -44.03M | 50.49M | -44.39M | 88.91M | -22.72M | -51.84M | -15.21M | -24.03M | -36.54M |
| Change in Receivables | -36.98M | -9.08M | -24.91M | -47.98M | 98.03M | -124.8M | 28.94M | -11.46M | -11.29M | -7.99M | -13.54M | -1.11M |
| Change in Inventory | -13.02M | 449.84K | 1.35M | -10.31M | 2.54M | -30.18M | -14.23M | -18.52M | -23.75M | -19.8M | -21.21M | -17.07M |
| Change in Payables | -21.4M | 21.73M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -9.95M | 0 | 0 |
| Cash from Investing | -6.86M | -3.3M | -53K | -4.34M | -703K | -384K | -503K | 608K | 7.16M | 6.65M | 22.22M | 46.96M |
| Capital Expenditures | -7.84M | -3.3M | -53K | -4.34M | -703K | -419K | -467K | -342K | -199K | 63K | -976K | -444K |
| CapEx % of Revenue | 3.13% | 1.34% | 0.02% | 2.74% | 0.7% | 0.24% | 0.81% | 0.95% | 0.21% | 0.05% | 2.03% | 0.94% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4.28K | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 974.77K | 0 | 0 | 0 | 0 | 36K | -36K | 950K | 0 | 5K | 46K | 0 |
| Cash from Financing | -37.44M | 8.36M | 38.85M | 6.98M | -18.02M | 87K | 427.87M | -2.46M | 18.42M | -6.05M | 143.36M | -2.31M |
| Debt Issued (Net) | -8.72M | -6.67M | -6.57M | -5.49M | -3.07M | -2.95M | -2.81M | -2.82M | -2.79M | -6.26M | 137.16M | -2.52M |
| Equity Issued (Net) | -20.56M | 15.08M | 44M | 0 | -17.4M | 19.29M | 0 | 0 | 0 | -1.81M | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | -52.71M | -90.01K | -588.32K | 0 | -17.4M | 0 | 0 | 0 | 0 | -1.81M | 0 | 0 |
| Other Financing | -8.15M | -58.96K | 1.43M | 12.47M | 2.44M | -16.26M | 430.69M | 365K | 21.21M | 2.02M | 6.19M | 208K |
| Net Change in Cash | -55.17M | 76.66M | 45.05M | -23.88M | -41.62M | -65.97M | 366.82M | -61.54M | -71.92M | -49.1M | 47.05M | -107.06M |
| Free Cash Flow | -15.69M | 67.37M | 2.1M | -11.68M | -15.02M | -87.56M | -56.6M | -61.65M | -101.78M | -42.41M | -125.69M | -153.57M |
| FCF Margin % | -6.26% | 27.48% | 0.98% | -7.39% | -14.87% | -50.35% | -97.86% | -171.26% | -106.14% | -30.8% | -261.68% | -324.04% |
| FCF Growth % | -4.47% | 176.95% | 103.71% | 81.06% | 85.25% | -106.47% | 54.97% | 59.86% | 31.29% | 70.85% | -23.24% | -19.87% |
| FCF per Share | -0.24 | 1.10 | 0.03 | -0.18 | -0.25 | -1.46 | -0.97 | -1.08 | -1.79 | -0.75 | -2.23 | -2.73 |
| FCF Conversion (FCF/Net Income) | -0.01x | -2.13x | -0.04x | 0.19x | 0.15x | 2.27x | 0.57x | 0.56x | 0.78x | 0.49x | 0.77x | 1.26x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 849K | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |